Healthcare
Tuesday, June 21, 2016
BRIEF-Redhill Biopharma announces positive final results with endpoints in phase 1 study with Yeliva
* Redhill Biopharma announces positive final results with
primary and secondary endpoints met in phase 1 study with
Yeliva in advanced solid tumors
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment